Researchers have discovered a previously unknown compound in chloraminated drinking water — a compound whose existence, if not its identity, has been known for 30 years. [ + ]

The plug-and-play test enables real-time monitoring of T cells that have been engineered to fight cancer, after reintroduction into the body of a cancer patient. [ + ]

Using complex computer models, researchers were able to prove that nanoplastic particles can bind the antibiotic known as tetracycline and thus impair its effectiveness. [ + ]

Beta blockers are unlikely to be needed for heart attack patients who have a normal pumping ability. There is also a risk that these patients will become depressed by the treatment. [ + ]

The L'Oréal-UNESCO For Women in Science initiative has honoured five trailblazing female scientists from ANZ, while ATSE has announced 250+ scholarships as part of its Elevate: Boosting diversity in STEM program. [ + ]

CRISPR molecular scissors have the potential to revolutionise the treatment of genetic diseases, but they can also lead to new defects when it comes to chronic granulomatous disease. [ + ]

Back in 2014, Dr Kelli MacDonald's lab at QIMR Berghofer identified the cellular process causing chronic GVHD as well as the antibody that could block this process. [ + ]

Professor Matthew Kiernan won the 2024 GSK Award for Research Excellence for his work in neurodegenerative disease, particularly MND and frontotemporal dementia. [ + ]

Frequent users of high-potency cannabis have changes in genes related to mitochondrial and immune function — particularly the CAVIN1 gene, which could affect energy and immune response. [ + ]

AusMAP aims to revolutionise the ways scientists address key questions and grand challenges in the fields of archaeology, palaeontology and the geosciences. [ + ]

Bacteria-based cancer therapy represents an exciting new treatment option — but in order to fully harness this approach, a safe and efficient method for producing natural anticancer bacteria is needed. [ + ]

The ACCC is concerned that the proposed acquisition would likely have the effect of substantially lessening competition in the supply of phase 1 clinical trials in Australia. [ + ]

Interim analysis of an mpox vaccine trial has found the vaccine is safe in adolescents and generates an antibody response equivalent to that seen in adults. [ + ]

Researchers have developed a novel treatment that is specific to breast cancer bone metastasis and can successfully work in the bone microenvironment, which is often resistant to therapeutics. [ + ]

Researchers demonstrated that their small, inexpensive device is feasible for identifying various PFAS families and detecting PFAS at levels as low as 400 ppt. [ + ]